BOLD vs CHTR · P/E 0.1, $24.6M cap vs P/E 11, rev $55.09B
Boundless Bio, Inc. Common Stock (BOLD) versus Charter Communications Inc (CHTR) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Not investment advice. Open the BOLD and CHTR stock pages for the full models.
Not investment advice.